Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
329540 | Neurobiology of Aging | 2006 | 15 Pages |
The goal of this study was to assess if neurons exposed to amyloid-β peptide (Aβ) exclusively in distal axons, undergo apoptosis. This is relevant to the loss of cholinergic neurons in Alzheimer's disease.Using a three-compartmented culture system for rat sympathetic neurons, we demonstrate that exposure of axons to Aβ1–42 activates an independent destruction program in axons, which leads to nuclear apoptosis. Aβ-induced axonal degeneration does not involve local caspase activation, but causes caspase activation in cell bodies. Accordingly, inhibition of caspase activation blocks Aβ-induced apoptosis but not axonal degeneration.In agreement with previous suggestions that disruption of nerve growth factor (NGF)-mediated signaling might contribute to the loss of cholinergic neurons, we found that provision of NGF to cell bodies protects sympathetic neurons from Aβ-induced apoptosis. However, our data indicate that Aβ-induced axonal degeneration follows a mechanism different than that activated by NGF withdrawal. Only Aβ-induced axonal degeneration is prevented by the calpain inhibitor calpastatin and is insensitive to the inhibitor of the ubiquitin–proteasome system MG132. Importantly, inhibition of Aβ-induced axonal degeneration by calpastatin prevents nuclear apoptosis.